These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34350076)

  • 21. Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey.
    Liu C; Tang S; An K; Zhang S; Zhou Y; Su N; Yang R; Liao X; An Z; Li S
    Front Pharmacol; 2021; 12():634561. PubMed ID: 34322016
    [No Abstract]   [Full Text] [Related]  

  • 22. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
    Elkind-Hirsch KE; Paterson MS; Seidemann EL; Gutowski HC
    Fertil Steril; 2017 Jan; 107(1):253-260.e1. PubMed ID: 28228317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occult metformin toxicity in three patients with profound lactic acidosis.
    Perrone J; Phillips C; Gaieski D
    J Emerg Med; 2011 Mar; 40(3):271-5. PubMed ID: 18571361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.
    DeFronzo RA; Buse JB; Kim T; Burns C; Skare S; Baron A; Fineman M
    Diabetologia; 2016 Aug; 59(8):1645-54. PubMed ID: 27216492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical development of metformin extended-release tablets for type 2 diabetes: an overview.
    Schwartz SL; Gordi T; Hou E; Cramer M; Heritier M; Cowles VE
    Expert Opin Drug Metab Toxicol; 2008 Sep; 4(9):1235-43. PubMed ID: 18721117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure.
    Gonzalez RR; Zweig S; Rao J; Block R; Greene LW
    Endocr Pract; 2007; 13(4):417-23. PubMed ID: 17669721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe hypoglycemia associated with levofloxacin in Type 2 diabetic patients receiving polytherapy: two case reports.
    Micheli L; Sbrilli M; Nencini C
    Int J Clin Pharmacol Ther; 2012 Apr; 50(4):302-6. PubMed ID: 22456302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Successful treatment of severe lactic acidosis caused by a suicide attempt with a metformin overdose.
    Yang PW; Lin KH; Lo SH; Wang LM; Lin HD
    Kaohsiung J Med Sci; 2009 Feb; 25(2):93-7. PubMed ID: 19321413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
    Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic simulations of topiramate plasma concentrations following dosing irregularities with extended-release vs. immediate-release formulations.
    Brittain ST; Wheless JW
    Epilepsy Behav; 2015 Nov; 52(Pt A):31-6. PubMed ID: 26409125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of high-flow high-volume-intermittent hemodiafiltration on metformin-associated lactic acidosis with circulatory failure: a case report.
    Suzuki K; Okada H; Yoshida S; Okamoto H; Suzuki A; Suzuki K; Yamada Y; Hayashi H; Yasuda R; Fukuta T; Kitagawa Y; Miyake T; Kawaguchi T; Watanabe T; Doi T; Kumada K; Ushikoshi H; Sugiyama T; Itoh Y; Ogura S
    J Med Case Rep; 2018 Sep; 12(1):280. PubMed ID: 30266098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin.
    Rosenstock J; Hansen L; Zee P; Li Y; Cook W; Hirshberg B; Iqbal N
    Diabetes Care; 2015 Mar; 38(3):376-83. PubMed ID: 25352655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy of sitagliptin as either monotherapy or add-on therapy to metformin: improvement in glycemic control over 2 years in patients with type 2 diabetes.
    Katzeff HL; Williams-Herman D; Xu L; Golm GT; Wang H; Dong Q; Johnson JR; O'Neill EA; Kaufman KD; Engel SS; Goldstein BJ
    Curr Med Res Opin; 2015 Jun; 31(6):1071-7. PubMed ID: 25850968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): a multicentre, cross-sectional study in Thailand.
    Satirapoj B; Pratipanawatr T; Ongphiphadhanakul B; Suwanwalaikorn S; Benjasuratwong Y; Nitiyanant W
    BMJ Open; 2020 Feb; 10(2):e031612. PubMed ID: 32051301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial choice of oral glucose-lowering medication for diabetes mellitus: a patient-centered comparative effectiveness study.
    Berkowitz SA; Krumme AA; Avorn J; Brennan T; Matlin OS; Spettell CM; Pezalla EJ; Brill G; Shrank WH; Choudhry NK
    JAMA Intern Med; 2014 Dec; 174(12):1955-62. PubMed ID: 25347323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paraneoplastic Encephalopathy in a Patient With Metastatic Lung Cancer: A Case Study.
    Rowley SM
    J Adv Pract Oncol; 2018 Mar; 9(2):216-221. PubMed ID: 30588355
    [No Abstract]   [Full Text] [Related]  

  • 37. Bioequivalence, Food Effect, and Steady-State Assessment of Dapagliflozin/Metformin Extended-release Fixed-dose Combination Tablets Relative to Single-component Dapagliflozin and Metformin Extended-release Tablets in Healthy Subjects.
    Chang M; Liu X; Cui D; Liang D; LaCreta F; Griffen SC; Lubin S; Quamina-Edghill D; Boulton DW
    Clin Ther; 2015 Jul; 37(7):1517-28. PubMed ID: 26048185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe and resistant hypoglycemia associated with concomitant gatifloxacin and glyburide therapy.
    LeBlanc M; Bélanger C; Cossette P
    Pharmacotherapy; 2004 Jul; 24(7):926-31. PubMed ID: 15303456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lantus insulin overdose: a case report.
    Lu M; Inboriboon PC
    J Emerg Med; 2011 Oct; 41(4):374-7. PubMed ID: 20493654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-release metformin hydrochloride. Single-composition osmotic tablet formulation.
    Wagstaff AJ; Figgitt DP
    Treat Endocrinol; 2004; 3(5):327-32. PubMed ID: 15330682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.